Highlights

  • Ensight v2.3 expands Enlitic’s commercial application suite from eight to 12.
  • The release adds operational analytics, archive standardisation and migration-focused capabilities.
  • A further major imaging-system integration broadens deployment Options for healthcare customers.
  • New applications can be added as subscriptions for existing Ensight customers.
  • Enlitic has outlined additional commercial applications planned for 2027.

Enlitic Inc. (ASX:ENL) develops artificial intelligence-enabled data management applications for medical imaging, with a focus on standardising, protecting, integrating and analysing healthcare data. On 6 October 2026, the company released Ensight v2.3, extending its platform from eight to 12 commercial applications and adding new functionality across migration, analytics and clinical workflow use cases.

What Ensight v2.3 Adds

The latest release introduces four applications. Productivity and Operational Analytics provides visibility into data-standardisation throughput and outcomes. Mass Archive Standardisation applies the company’s standardisation process across historical imaging archives at scale, while Integrated Migration and Archive Standardisation is designed to improve data consistency as information moves into a new environment. The fourth application uses standardised data to support automated case allocation to appropriate radiologists.

The release also includes an export interface for standardised study and series data, updates to artificial intelligence models used for X-ray and de-identification workflows, and faster incremental processing through transferable configuration profiles.

Expanded Integration Pathway

Enlitic said Ensight v2.3 adds another major medical-imaging system integration, expanding the range of environments in which the platform can operate without requiring healthcare organisations to replace their core imaging infrastructure. The company also expects a third major original-equipment-manufacturer integration to complete customer validation before the end of 2026.

This approach supports Enlitic’s strategy of entering healthcare environments through data migration or standardisation projects and then offering additional applications as subscription services. The company stated that its migration and archive-standardisation integration interface is intended to create a more direct pathway from project-based work to recurring subscriptions.

Customer Deployment and Commercial Model

A customer project announced in September 2026 provides an example of the platform’s deployment at scale. The project includes standardisation of a historical imaging archive with approximately 10.6 million radiology and cardiology studies in scope. Enlitic did not disclose Revenue or contract-value figures linked to the new v2.3 applications in the 6 October announcement.

The commercial effect of the expanded platform will therefore depend on adoption by existing and future customers. Enlitic noted that the additional applications can be purchased as subscriptions by current Ensight users, but it did not quantify expected subscription uptake or annualised Recurring Revenue from the release.

Product Roadmap

Enlitic has also outlined five further commercial applications planned for 2027. These are expected to extend the platform into areas including coding, billing optimisation, research data management and bulk de-identification. The company has not provided individual release dates for those applications.

Key Insights

Ensight v2.3 broadens Enlitic’s medical imaging data platform across migration, operational analytics and workflow functions while increasing the number of applications available to customers. The release also expands interoperability options and supports the company’s subscription-based commercial model. Near-term points to monitor include completion of the pending integration validation before the end of 2026 and customer adoption of the additional applications.